form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
July 14, 2011
(Date of earliest event reported)
LABORATORY CORPORATION OF
AMERICA HOLDINGS
(Exact Name of Registrant as Specified in its Charter)
|
Delaware
|
|
1-11353
|
|
13-3757370
|
|
(State or other jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
358 South Main Street,
|
|
|
|
|
|
Burlington, North Carolina
|
|
27215
|
|
336-229-1127
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
(Registrant’s telephone number including area code)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
[ ]
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Laboratory Corporation of America Holdings has reached an agreement in principle to settle the previously disclosed lawsuit, California ex rel. Hunter Laboratories, LLC v. Quest Diagnostics Incorporated, et al., to avoid the uncertainty and costs associated with prolonged litigation. The original lawsuit was brought against the Company and several other major laboratories operating in California and alleged that the defendants improperly billed California’s Medicaid program. The settlement in principle provides that the Company will pay $49.5 million to resolve all claims brought against the Company in the lawsuit. As a result of the settlement in principle, the Company has recorded a Second Quarter pre-tax charge of $34.5 million (net of a previously recorded reserve of $15.0 million), $20.7 million after tax. The settlement is subject to the negotiation and execution of a Settlement Agreement and Release.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Registrant
| |
By:
|
/s/ F. SAMUEL EBERTS III
|
| |
|
F. Samuel Eberts III
|
| |
|
Chief Legal Officer and Secretary
|
July 14, 2011